Safety and immunogenicity of the iNTS-GMMA vaccine
<p>Invasive non-typhoidal <em>Salmonella</em> (iNTS) is a common cause of bacteraemia in sub-Saharan Africa, where it particularly affects children under five. In this thesis, I outline SALVO (<em>Salmonella</em> Vaccine Study in Oxford), a first-in-human phase I rando...
Main Author: | Hanumunthadu, B |
---|---|
Other Authors: | Hill, J |
Format: | Thesis |
Language: | English |
Published: |
2023
|
Subjects: |
Similar Items
-
The iNTS-GMMA vaccine: a promising step in non-typhoidal Salmonella vaccine development
by: Peter D Skidmore, et al.
Published: (2023-12-01) -
Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort
by: Hanumunthadu, B, et al.
Published: (2023) -
Analysis of genome and virulence characteristics of seven invasive non-typhoidal Salmonella (iNTS)
by: HU Yujie, et al.
Published: (2021-05-01) -
Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort
by: Melita A Gordon, et al.
Published: (2023-11-01) -
A GMMA-CPS-Based Vaccine for Non-Typhoidal <i>Salmonella</i>
by: Akosiererem S. Sokaribo, et al.
Published: (2021-02-01)